Tamim Mahayni, DO
Pulmonary Disease · Ames, IANPI 1184935132
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,515 of the $7,973 with a category attached, or 69.2%. Intuitive Surgical accounts for 99.0% of it on its own, with 2 other manufacturers making up the rest.
Across 16 payments — averaging $498.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- GSK$66
- Boehringer Ingelheim$15
What the payments were for
- Travel & lodging$2,38230%
- Food & beverage$761%
- Education$5,51569%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $7,892 |
| GSK | 1 | $66 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,792
How this compares
$7,973 in reported general payments places this provider in the 75th percentile of 110 pulmonary disease providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 1,074 | $746,122 |
| OfevNintedanib Esylate | 28 | $355,699 |
| Breo ElliptaFluticasone/Vilanterol | 548 | $224,563 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 75 | $40,110 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 91 | $39,804 |
| SymbicortBudesonide/Formoterol Fumarate | 94 | $30,879 |
| Arnuity ElliptaFluticasone Furoate | 68 | $23,770 |
| Incruse ElliptaUmeclidinium Bromide | 35 | $17,816 |
| Advair HfaFluticasone Propion/Salmeterol | 40 | $17,308 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $16,624 |
| Spiriva HandihalerTiotropium Bromide | 24 | $15,893 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 122 | $15,775 |
| Spiriva RespimatTiotropium Bromide | 22 | $11,196 |
| Serevent DiskusSalmeterol Xinafoate | 20 | $8,327 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 306 | $7,675 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta | $66 | $1,052,0751,816 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat, Combivent Respimat | $15 | $413,778136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 110 pulmonary disease providers in Iowa.
Other pulmonary disease in Ames
- Taher SabobehAmes$3K
- Bryan KrajicekCouncil Bluffs$470K
- Sumit MukherjeeCouncil Bluffs$264K
- John SouthardCouncil Bluffs$184K
- Dustin McCannWest Des Moines$67K
- Alejandro ComellasIowa City$54K
- Matthew TrumpWest Des Moines$41K
- Brian WittDavenport$19K
- Shrey VelaniDes Moines$18K
- James MallenWest Des Moines$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.